{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:13:17Z","timestamp":1791486797535,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"publisher","award":["213636"],"award-info":[{"award-number":["213636"]}],"id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"publisher","award":["EPI-STREP-121"],"award-info":[{"award-number":["EPI-STREP-121"]}],"id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128349","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:34:26Z","timestamp":1771248866000},"page":"128349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease in Vietnamese children prior to national introduction: A matched case-control study"],"prefix":"10.1016","volume":"77","author":[{"given":"Hieu Cong","family":"Truong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang Duy","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Van","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai Thi Trang","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc Duy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhan Nguyen Thanh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung Huu","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qui Dinh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Tran","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh Tuyet","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Soetewey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung Vu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuong Vu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"Speybroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2026.128349_bb0005","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128349_bb0010","unstructured":"World Health Organization (WHO). Pneumococcal Conjugate Vaccines in Infants and Children Aged <5 years: WHO Position Paper \u2013 September 2025. Geneva: World Health Organization; 2025. Available from: https:\/\/www.who.int\/publications\/i\/item\/who-wer10039-411-437. Accessed 29 September 2025."},{"key":"10.1016\/j.vaccine.2026.128349_bb0015","unstructured":"Ryan Gierke, A. Patricia Wodi, Miwako Kobayashi. Pneumococcal Disease. In: Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book). Centers for Disease Control and Prevention; 2024. Chapter 17. 2024. Available from: https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/chapter-17-pneumococcal-disease.html. Accessed 10 August 2025."},{"key":"10.1016\/j.vaccine.2026.128349_bb0020","doi-asserted-by":"crossref","unstructured":"Garcia Quesada M, Peterson ME, Bennett JC, et al. Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis. Lancet Infect Dis Published online April 1, 2025. doi:https:\/\/doi.org\/10.1016\/S1473-3099(24)00588-7.","DOI":"10.1016\/S1473-3099(24)00588-7"},{"key":"10.1016\/j.vaccine.2026.128349_bb0025","unstructured":"Centers for Disease Control and Prevention (CDC). Manual for the Surveillance of Vaccine-Preventable Diseases. Chapter 11: Pneumococcal disease. Atlanta (GA): CDC; 2025. Available from: https:\/\/www.cdc.gov\/surv-manual\/php\/table-of-contents\/chapter-11-pneumococcal.html. Accessed 15 September 2025."},{"key":"10.1016\/j.vaccine.2026.128349_bb0030","unstructured":"International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub: Current Vaccine Introduction Status (2025). Available from: https:\/\/view-hub.org\/vaccine\/pcv. Accessed 10 August 2025."},{"issue":"6","key":"10.1016\/j.vaccine.2026.128349_bb0035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/tmi.12874","article-title":"Disease spectrum and management of children admitted with acute respiratory infection in Viet Nam","volume":"22","author":"Nguyen","year":"2017","journal-title":"Trop Med Inte Health"},{"key":"10.1016\/j.vaccine.2026.128349_bb0040","doi-asserted-by":"crossref","unstructured":"Hoang VT, Dao TL, Minodier P, et al. Risk Factors for Severe Pneumonia According to WHO 2005 Criteria Definition Among Children <5 Years of Age in Thai Binh, Vietnam: A Case\u2013Control Study. Int J Comput Intell Syst 2019;9(4):274\u2013280. doi:https:\/\/doi.org\/10.2991\/jegh.k.191009.001.","DOI":"10.2991\/jegh.k.191009.001"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128349_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-024-10065-0","article-title":"Epidemiology of pneumococcal meningitis in sentinel hospital surveillance of Viet Nam, 2015\u20132018","volume":"24","author":"Nguyen","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128349_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102797","article-title":"Clinical features and antibiotic resistance in pediatric pneumococcal meningitis in southern Vietnam, 2012\u20132023: a multicenter retrospective study","volume":"18","author":"Truong","year":"2025","journal-title":"J Infect Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128349_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1473-3099(24)00665-0","article-title":"Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis","volume":"25","author":"Bennett","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128349_bb0060","unstructured":"World Health Organization (WHO). Pneumococcal conjugate vaccines in infants and children aged <5 years: WHO position paper - February 2019. Geneva: World Health Organization; 2019. Available from: https:\/\/www.who.int\/publications\/i\/item\/10665-310968. Accessed 10 August 2025."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128349_bb0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128349_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.128349_bb0075","unstructured":"World Bank. Population, total - Vietnam. Washington (DC): World Bank Group; 2025. Available from: https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL?locations=VN&utm. Accessed 15 November 2025."},{"key":"10.1016\/j.vaccine.2026.128349_bb0080","unstructured":"National Statistics Office (Vietnam). Socio-economic situation in the fourth quarter and 2024. Hanoi: National Statistics Office; 2025. Available from: https:\/\/www.nso.gov.vn\/en\/highlight\/2025\/02\/socio-economic-situation-in-the-fourth-quarter-and-2024\/. Accessed 20 November 2025."},{"issue":"7","key":"10.1016\/j.vaccine.2026.128349_bb0085","article-title":"Childhood bacterial meningitis surveillance in southern Vietnam: trends and vaccination implications from 2012 to 2021. Open forum","volume":"10","author":"Truong","year":"2023","journal-title":"Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128349_bb0090","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/JCM.02927-12","article-title":"Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden","volume":"51","author":"Pimenta","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128349_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115037","article-title":"Expanded sequential quadriplex real-time polymerase chain reaction (PCR) for identifying pneumococcal serotypes, penicillin susceptibility, and resistance markers","volume":"97","author":"Velusamy","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128349_bb0100","unstructured":"World Health Organization & Centers for Disease Control and Prevention (U.S.) (2011). Laboratory methods for the diagnosis of meningitis caused by Neisseria Meningitidis, streptococcus pneumoniae, and Haemophilus Influenzae: WHO manual, 2nd Edition. World Health Organization. Available from: https:\/\/iris.who.int\/handle\/10665\/70765. Accessed 20 November 2025."},{"issue":"9468","key":"10.1016\/j.vaccine.2026.128349_bb0105","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(05)66379-9","article-title":"Compared to what? Finding controls for case-control studies","volume":"365","author":"Grimes","year":"2005","journal-title":"Lancet Elsevier BV"},{"issue":"25","key":"10.1016\/j.vaccine.2026.128349_bb0110","first-page":"3295","article-title":"Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls","volume":"35","author":"Verani","year":"2017","journal-title":"Vaccine Elsevier Ltd"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128349_bb0115","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2307\/2531743","article-title":"Power calculations for matched case-control studies","volume":"44","author":"Dupont","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2026.128349_bb0120","series-title":"Methods in observational epidemiology","author":"Kelsey","year":"1996"},{"key":"10.1016\/j.vaccine.2026.128349_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijid.2018.12.007","article-title":"Effectiveness of 10-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in Pakistan","volume":"80","author":"Riaz","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128349_bb0130","first-page":"1126","article-title":"Methodological issues in design and analysis of a matched case-control study of a vaccine\u2019s effectiveness","volume":"166","author":"Niccolai","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128349_bb0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","volume":"4","author":"Moore","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128349_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"Domingues","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128349_bb0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2307\/2529548","article-title":"Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data","volume":"31","author":"Ury","year":"1975","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128349_bb0150","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/INF.0000000000001054","article-title":"Effectiveness of pneumococcal conjugate vaccines of different valences against invasive pneumococcal disease among children in Taiwan: a nationwide study","volume":"35","author":"Su","year":"2016","journal-title":"Pediatric Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128349_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3047-3","article-title":"Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic","volume":"18","author":"Tomczyk","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128349_bb0160","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S2214-109X(17)30043-8","article-title":"Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in south African children: a case-control study","volume":"5","author":"Cohen","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128349_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183191","article-title":"Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study","volume":"12","author":"Dom\u00ednguez","year":"2017","journal-title":"PloS One"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128349_bb0170","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.vaccine.2015.04.005","article-title":"Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada","volume":"33","author":"Deceuninck","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128349_bb0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128349_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161257","article-title":"Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany","volume":"11","author":"Van Der Linden","year":"2016","journal-title":"PloS One"},{"issue":"9546","key":"10.1016\/j.vaccine.2026.128349_bb0185","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128349_bb0190","doi-asserted-by":"crossref","unstructured":"Vesikari T, Wysocki J, Chevallier B, et al. Immunogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatric Infect Dis J 2009;28(SUPPL. 4). doi:https:\/\/doi.org\/10.1097\/INF.0b013e318199f8ef.","DOI":"10.1097\/INF.0b013e318199f8ef"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128349_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-025-10672-5","article-title":"Serotype distribution of invasive pneumococcal disease in a tertiary children\u2019s hospital in Vietnam","volume":"25","author":"Do","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128349_bb0200","unstructured":"Ministry of Health (Vietnam). Decision no.2780\/QD-BYT approving the expanded program on immunization plan for the 2026\u20132028 period. Hanoi: Ministry of Health; 2025."},{"key":"10.1016\/j.vaccine.2026.128349_bb0205","series-title":"Fundamentals of biostatistics","author":"Rosner","year":"2016"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128349_bb0210","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/oxfordjournals.aje.a116397","article-title":"Selection of controls in case-control studies: II. Types of controls","volume":"135","author":"Wacholder","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128349_bb0215","unstructured":"Government of Vietnam. Decree no.30\/2025\/ND-CP Amending and Supplementing a Number of Articles of Decree No.07\/2021\/ND-CP on Multidimensional Poverty Standards for the Period 2021\u20132025; 2025."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:23:21Z","timestamp":1777537401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"alternative-id":["S0264410X2600157X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128349","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease in Vietnamese children prior to national introduction: A matched case-control study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128349"}}